Werewolf Therapeutics ( (HOWL) ) just unveiled an update. Werewolf Therapeutics is pioneering the development of innovative cytokine therapies ...
Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...
The expansion of therapeutic applications of botulinum toxin is likely prevail as a key trend in the market during the forecast period. Other factors that are expected to favor the growth of the ...